Clinical Research Demo Drug Development 
H1 Blog
JULY 30, 2024
The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. The Impact of Draft Guidance on Drug Development As it stands, drug development is an expensive endeavor, costing approximately $2.3
H1 Blog
MAY 4, 2023
Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.
H1 Blog
NOVEMBER 29, 2023
Breaking the Barriers: How Inaccurate Trial Records Are Delaying Drug Development and Limiting Diverse Patient Populations In an October 2023 report , BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical trials.
Expert insights. Personalized for you.
59 
Let's personalize your content